ELRAVIE PREMIER LIGHT-L LIDOCAINE

ELRAVIE PREMIER LIGHT-L LIDOCAINE

ELRAVIE PREMIER LIGHT-L LIDOCAINE is a refined dermal filler developed by Humedix to address fine lines and the more delicate signs of facial aging. Formulated with 23 mg/ml of stabilized hyaluronic acid and 3 mg/ml of lidocaine, it provides both subtle volume enhancement and a comfortable treatment experience. The product utilizes advanced HI Technology (High molecular Ideal reticulated Matrix) to create a stable, resilient gel that delivers natural, long-lasting results.

Key Benefits of ELRAVIE PREMIER LIGHT-L LIDOCAINE

• Features cross-linked hyaluronic acid for effective fine line correction

• Contains lidocaine for enhanced patient comfort during and after injection

• CE-marked, ensuring high safety and quality standards

This filler is ideal for:

1. Adults over 21 seeking to correct superficial wrinkles and enhance facial contours

2. Patients desiring subtle lip enhancement or fine line reduction

Recommended Treatment Areas

• Naso-labial folds for gentle smoothing

• Lip enhancement to restore natural fullness

• Character lines and crow’s feet for a refreshed look

• Other fine lines and shallow creases across the face

How ELRAVIE PREMIER LIGHT-L LIDOCAINE Works?

• Utilizes HI Technology to stabilize hyaluronic acid into an optimal matrix, improving crosslinking efficiency

• Special activation of hyaluronic acid molecules multiplies compound formation during crosslinking while reducing BDDE levels

• Results in a highly stable, smooth gel that resists mechanical stress and integrates well into tissue

Application and Professional Use

• Intended for administration by licensed medical professionals experienced in aesthetic treatments

• A thorough review of the patient’s medical history is recommended prior to use

• The treatment area should be cleaned, marked, and disinfected before injection

• The filler is injected at the appropriate dermal depth based on the correction needed

• Gentle massage helps distribute the product evenly across the treated area

Expected Duration of Results

• Results typically last between 9 and 12 months, depending on the individual’s physiology and lifestyle

Safety Information of ELRAVIE PREMIER LIGHT-L LIDOCAINE
While generally safe for most patients, certain individuals should avoid use:

• Those allergic to any ingredient in the formulation

• People under 21 years of age

• Pregnant or breastfeeding women

Potential temporary side effects include:

1. Bruising

2. Redness

3. Pain

4. Itching

Post-Treatment Guidelines of ELRAVIE PREMIER LIGHT-L LIDOCAINE

• Patients may resume daily activities immediately

• It is advised to avoid vigorous exercise, direct sun exposure, and alcohol consumption for 24 hours after treatment

Packaging Details

• Supplied in a 1 ml pre-filled syringe with a 30G needle for precise application

ELRAVIE PREMIER LIGHT-L LIDOCAINE offers a subtle yet effective solution for fine wrinkles, enhancing the skin’s natural glow and achieving visibly smoother, rejuvenated facial contours.